Company Profile (AI Text)
Name: Egret Therapeutics Inc.
Canonical URL: https://wefunder.com/egret.therapeutics
Updated at: 2026-08-03T23:54:01Z

Tagline: Redefining Recovery After Devastating Injuries

Key claims:
- Total raised on Wefunder: 87000 | citation: https://wefunder.com/egret.therapeutics#claim-total-raised
- Total investors: 4 | citation: https://wefunder.com/egret.therapeutics#claim-total-investors

Verified facts:
- Total raised on Wefunder: 87000 | observed_at: 2026-08-03T23:54:01Z | expires_at: 2026-08-04T23:54:01Z
- Total investors: 4 | observed_at: 2026-08-03T23:54:01Z | expires_at: 2026-08-04T23:54:01Z

Computed metrics:
- total_amount_raised: 87000
- total_investors: 4
- team_size: 10
- featured_investor_count: 2
- faq_count: 1
- recent_post_count: 0

Quick facts:
- The same immune response drives a second wave of damage after CNS, cardiac and orthopedic injury. | citation: https://wefunder.com/egret.therapeutics#claim-fact-1
- Prior programs tried to block this immune response and failed - blockade also suppresses repair. | citation: https://wefunder.com/egret.therapeutics#claim-fact-2
- We found a switch that reprograms these immune cells from destructive to protective. | citation: https://wefunder.com/egret.therapeutics#claim-fact-3
- EGT-101 is our first-in-class therapy to flip this switch - Phase 1 complete, clean safety profile. | citation: https://wefunder.com/egret.therapeutics#claim-fact-4
- Phase 1b proof-of-principle trial tracks ICU signals: less swelling, fewer surgeries. | citation: https://wefunder.com/egret.therapeutics#claim-fact-5
- Co-founded by Stanford's Chair of Neurosurgery and a Johns Hopkins Neurosurgeon. | citation: https://wefunder.com/egret.therapeutics#claim-fact-6
- $7.5M funds Phase 1b readout - enables Phase 2, pipeline expansion, and licensing and M&A talks. | citation: https://wefunder.com/egret.therapeutics#claim-fact-7
- Beachhead market is a ~$1B peak sales opportunity; the underlying biology unlocks broader platform. | citation: https://wefunder.com/egret.therapeutics#claim-fact-8

FAQ:
- Q: can you please lower the min to invest to $100? Thanks
  A: Hi Samuel, thank you for your interest in Egret. At this time, we've decided to keep the minimum investment at $1,000 to maintain consistency for all investors in this round. If you're looking to invest at a lower threshold, we encourage you to follow our page - we plan to open a Reg CF round in the future with a lower minimum.